Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? (Deficit) Equity

v3.23.3
Condensed Consolidated Statements of Stockholders’ (Deficit) Equity - USD ($)
$ in Thousands
Total
Bird Canada Inc.
Common Stock
Common Stock
Bird Canada Inc.
Common Stock
Acquisition of Spin
Additional Paid-In Capital
Additional Paid-In Capital
Bird Canada Inc.
Additional Paid-In Capital
Acquisition of Spin
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021     10,904,958              
Beginning balance at Dec. 31, 2021 $ 301,731   $ 27     $ 1,475,300     $ 7,538 $ (1,181,134)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 7,748                 7,748
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises (in shares)     33,744              
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises 169         169        
Issuance of Common Stock through settlement of restricted stock units (in shares)     72,690              
Shares of Common Stock withheld related to net share settlement (in shares)     (24,318)              
Shares of Common Stock withheld related to net share settlement (1,903)         (1,903)        
Stock-based compensation expense 48,704         48,704        
Foreign currency translation adjustment (4,473)               (4,473)  
Ending balance (in shares) at Mar. 31, 2022     10,987,074              
Ending balance at Mar. 31, 2022 351,976   $ 27     1,522,270     3,065 (1,173,386)
Beginning balance (in shares) at Dec. 31, 2021     10,904,958              
Beginning balance at Dec. 31, 2021 301,731   $ 27     1,475,300     7,538 (1,181,134)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (322,334)                  
Foreign currency translation adjustment (19,216)                  
Ending balance (in shares) at Sep. 30, 2022     11,666,345              
Ending balance at Sep. 30, 2022 43,673   $ 29     1,558,790     (11,678) (1,503,468)
Beginning balance (in shares) at Mar. 31, 2022     10,987,074              
Beginning balance at Mar. 31, 2022 351,976   $ 27     1,522,270     3,065 (1,173,386)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (320,316)                 (320,316)
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises (in shares)     9,148              
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises 88         88        
Issuance of Common Stock through settlement of restricted stock units (in shares)     224,483              
Issuance of Common Stock through settlement of restricted stock units 1   $ 1              
Shares of Common Stock withheld related to net share settlement (in shares)     (5,778)              
Shares of Common Stock withheld related to net share settlement (108)         (108)        
Issuance of ATM Facility Shares, net of fees (in shares)     2,897              
Issuance of ATM Facility Shares, net of fees 56         56        
Stock-based compensation expense 43,650         43,650        
Foreign currency translation adjustment (11,563)               (11,563)  
Ending balance (in shares) at Jun. 30, 2022     11,217,824              
Ending balance at Jun. 30, 2022 63,784   $ 28     1,565,956     (8,498) (1,493,702)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (9,766)                 (9,766)
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises (in shares)     33,370              
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises 114         114        
Issuance of Common Stock through settlement of restricted stock units (in shares)     157,736              
Issuance of Common Stock through settlement of restricted stock units     $ 0              
Shares of Common Stock withheld related to net share settlement (in shares)     (14,682)              
Shares of Common Stock withheld related to net share settlement (150)         (150)        
Issuance of Common Stock under the Purchase Agreement (in shares)     269,200              
Issuance of Common Stock under the Purchase Agreement 3,155   $ 1     3,154        
Issuance of ATM Facility Shares, net of fees (in shares)     2,897              
Issuance of ATM Facility Shares, net of fees 32         32        
Stock-based compensation expense (10,316)         (10,316)        
Foreign currency translation adjustment (3,180)               (3,180)  
Ending balance (in shares) at Sep. 30, 2022     11,666,345              
Ending balance at Sep. 30, 2022 43,673   $ 29     1,558,790     (11,678) (1,503,468)
Beginning balance (in shares) at Dec. 31, 2022     11,889,227              
Beginning balance at Dec. 31, 2022 25,110   $ 30     1,572,576     (7,621) (1,539,875)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (44,318)                 (44,318)
Issuance of Common Stock through acquisition transaction (in shares)       728,175            
Issuance of Common Stock through acquisition transaction   $ 3,696   $ 2     $ 3,694      
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises (in shares)     50,097              
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises 205         205        
Issuance of Common Stock through settlement of restricted stock units (in shares)     97,682              
Shares of Common Stock withheld related to net share settlement (in shares)     (535)              
Shares of Common Stock withheld related to net share settlement (4)         (4)        
Stock-based compensation expense 7,280         7,280        
Foreign currency translation adjustment 461               461  
Ending balance (in shares) at Mar. 31, 2023     12,764,646              
Ending balance at Mar. 31, 2023 (7,570)   $ 32     1,583,751     (7,160) (1,584,193)
Beginning balance (in shares) at Dec. 31, 2022     11,889,227              
Beginning balance at Dec. 31, 2022 25,110   $ 30     1,572,576     (7,621) (1,539,875)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (73,440)                  
Foreign currency translation adjustment (707)                  
Ending balance (in shares) at Sep. 30, 2023     15,564,414              
Ending balance at Sep. 30, 2023 (25,162)   $ 32     1,596,449     (8,328) (1,613,315)
Beginning balance (in shares) at Mar. 31, 2023     12,764,646              
Beginning balance at Mar. 31, 2023 (7,570)   $ 32     1,583,751     (7,160) (1,584,193)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (9,310)                 (9,310)
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises (in shares)     28,793              
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises 45         45        
Issuance of Common Stock through settlement of restricted stock units (in shares)     88              
Stock-based compensation expense 5,921         5,921        
Foreign currency translation adjustment (11)               (11)  
Ending balance (in shares) at Jun. 30, 2023     12,793,527              
Ending balance at Jun. 30, 2023 (10,925)   $ 32     1,589,717     (7,171) (1,593,503)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (19,812)                 (19,812)
Issuance of Common Stock through acquisition transaction (in shares)         1,608,623          
Issuance of Common Stock through acquisition transaction         $ 2,300     $ 2,300    
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises (in shares)     12,165              
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises 6   $ 0     6        
Issuance of Common Stock through settlement of restricted stock units (in shares)     837,256              
Issuance of ATM Facility Shares, net of fees (in shares)     312,843              
Issuance of ATM Facility Shares, net of fees 191         191        
Stock-based compensation expense 4,235         4,235        
Foreign currency translation adjustment (1,157)               (1,157)  
Ending balance (in shares) at Sep. 30, 2023     15,564,414              
Ending balance at Sep. 30, 2023 $ (25,162)   $ 32     $ 1,596,449     $ (8,328) $ (1,613,315)